Your browser doesn't support javascript.
loading
Identification of two preclinical canine models of atrial fibrillation to facilitate drug discovery.
Freudenberger, Till; Kranz, Beate; Lehmann, Waldemar; Schäfer, Katja; Münter, Klaus; Lee, Kichang; Ellinor, Patrick T; Hucker, William J.
Affiliation
  • Freudenberger T; Bayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany. Electronic address: till.freudenberger@bayer.com.
  • Kranz B; Bayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany.
  • Lehmann W; Bayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany.
  • Schäfer K; Bayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany.
  • Münter K; Bayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany.
  • Lee K; Cardiac Arrhythmia Service & Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Ellinor PT; Cardiac Arrhythmia Service & Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts. Electronic address: ellinor@mgh.harvard.edu.
  • Hucker WJ; Cardiac Arrhythmia Service & Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Heart Rhythm ; 18(4): 632-640, 2021 04.
Article in En | MEDLINE | ID: mdl-33346136
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Carbachol / Drug Discovery Type of study: Diagnostic_studies Limits: Animals Language: En Journal: Heart Rhythm Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Carbachol / Drug Discovery Type of study: Diagnostic_studies Limits: Animals Language: En Journal: Heart Rhythm Year: 2021 Type: Article